These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 29638022)

  • 21. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.
    Dell'Aquila M; Granitto A; Martini M; Capodimonti S; Cocomazzi A; Musarra T; Fiorentino V; Pontecorvi A; Lombardi CP; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
    Cancer Cytopathol; 2020 Mar; 128(3):177-189. PubMed ID: 31821747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the rate of malignancy for atypia of undetermined significance subcategories.
    Hang JF; Westra WH; Zhou AG; Cooper DS; Ali SZ
    Cancer Cytopathol; 2018 May; 126(5):309-316. PubMed ID: 29424960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytological Diagnoses Associated with Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features According to the Bethesda System for Reporting Thyroid Cytopathology: A Systematic Review and Meta-Analysis.
    Bongiovanni M; Giovanella L; Romanelli F; Trimboli P
    Thyroid; 2019 Feb; 29(2):222-228. PubMed ID: 30426887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology.
    Faquin WC; Wong LQ; Afrogheh AH; Ali SZ; Bishop JA; Bongiovanni M; Pusztaszeri MP; VandenBussche CJ; Gourmaud J; Vaickus LJ; Baloch ZW
    Cancer Cytopathol; 2016 Mar; 124(3):181-7. PubMed ID: 26457584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of distinct cytomorphologic features in the diagnosis of NIFTP at the time of preoperative FNA: Implications for patient management.
    Chandler JB; Colunga M; Prasad ML; Callender GG; Quinn C; Chhieng D; Adeniran AJ
    Cancer Cytopathol; 2017 Nov; 125(11):865-875. PubMed ID: 28834409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytologic and clinical features of NIFTP: Can we diagnose based on preoperative fine-needle aspiration.
    Yan L; Sethi S; Park JW
    Diagn Cytopathol; 2019 Dec; 47(12):1259-1266. PubMed ID: 31444953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Prospective Analysis.
    Strickland KC; Vivero M; Jo VY; Lowe AC; Hollowell M; Qian X; Wieczorek TJ; French CA; Teot LA; Sadow PM; Alexander EK; Cibas ES; Barletta JA; Krane JF
    Thyroid; 2016 Oct; 26(10):1466-1471. PubMed ID: 27457786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytological Diagnosis of Follicular Variant of Papillary Thyroid Carcinoma before and after the Bethesda System for Reporting Thyroid Cytopathology.
    Fazeli R; VandenBussche CJ; Bishop JA; Ali SZ
    Acta Cytol; 2016; 60(1):14-8. PubMed ID: 27007511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of the non-invasive follicular thyroid neoplasm with papillary-like nuclear feature terminology in the routine diagnosis of thyroid tumours.
    Jaconi M; Manzoni M; Pincelli AI; Giardini V; Scardilli M; Smith A; Fellegara G; Pagni F
    Cytopathology; 2017 Dec; 28(6):495-502. PubMed ID: 28868665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of the reclassification of NIFTP as an uncertain tumour on risk of malignancy for the diagnostic categories according to the Bethesda system for reporting thyroid cytopathology.
    Kopczyński J; Suligowska A; Niemyska K; Palyga I; Walczyk A; Gąsior-Perczak D; Kowalik A; Hińcza K; Mężyk R; Góźdź S; Kowalska A
    Endokrynol Pol; 2019; 70(3):232-236. PubMed ID: 30845342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High risk of malignancy in cases with atypia of undetermined significance on fine needle aspiration of thyroid nodules even after exclusion of NIFTP.
    Özkara SK; Bayrak BY; Turan G
    Diagn Cytopathol; 2020 Nov; 48(11):986-997. PubMed ID: 32745375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasound findings of noninvasive follicular thyroid neoplasm with papillary-like nuclear features compared with those of follicular variant of papillary carcinoma and encapsulated papillary carcinoma: a single-institution study in Japan.
    Oshita M; Ito Y; Miyamoto T; Ota H; Nakamura T; Hirokawa M; Miya A; Miyauchi A
    Endocr J; 2020 Nov; 67(11):1147-1155. PubMed ID: 32669481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
    Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
    Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CLINICAL IMPACT OF NON-INVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES ON THE RISK OF MALIGNANCY IN THE BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY: A META-ANALYSIS OF 14,153 RESECTED THYROID NODULES.
    Vuong HG; Tran TTK; Bychkov A; Jung CK; Nakazawa T; Kakudo K; Katoh R; Kondo T
    Endocr Pract; 2019 May; 25(5):491-502. PubMed ID: 30657357
    [No Abstract]   [Full Text] [Related]  

  • 35. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features reclassification and its impact on thyroid malignancy rate and treatment.
    Mao ML; Joyal T; Picado O; Kerr D; Lew JI; Farrá JC
    J Surg Res; 2018 Oct; 230():47-52. PubMed ID: 30100039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Bethesda system for reporting thyroid cytopathology: an institutional experience of the outcome of indeterminate categories.
    Onder S; Firat P; Ates D
    Cytopathology; 2014 Jun; 25(3):177-84. PubMed ID: 23998291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
    Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA
    Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Reclassification on Thyroid Nodules with Architectural Atypia: From Non-Invasive Encapsulated Follicular Variant Papillary Thyroid Carcinomas to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.
    Jeon MJ; Song DE; Jung CK; Kim WG; Kwon H; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
    PLoS One; 2016; 11(12):e0167756. PubMed ID: 27936121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of risk of neoplasm as an outcome in cytologic-histologic correlation studies on thyroid fine needle aspiration.
    Chen YH; Partyka KL; Dougherty R; Cramer HM; Wu HH
    Diagn Cytopathol; 2020 Dec; 48(12):1237-1243. PubMed ID: 32716614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features and the risk of malignancy in The Bethesda System for the Reporting of Thyroid Cytopathology.
    Elliott Range D; Jiang XS
    Diagn Cytopathol; 2020 Jun; 48(6):531-537. PubMed ID: 32167682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.